[Advanced cancer of the ovary. The paclitaxel-cisplatin combination as the first-line standard of treatment].
S
S
Pecorelli
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000401:mortality; D017239:Paclitaxel / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel; D002945:Cisplatin
Il cancro avanzato dell'ovaio. La associazione paclitaxel-cisplatino quale standard di trattamento di prima linea.